SE9700983D0 - Stimulering, odling och preservation av pankreas- och andra celler - Google Patents

Stimulering, odling och preservation av pankreas- och andra celler

Info

Publication number
SE9700983D0
SE9700983D0 SE9700983A SE9700983A SE9700983D0 SE 9700983 D0 SE9700983 D0 SE 9700983D0 SE 9700983 A SE9700983 A SE 9700983A SE 9700983 A SE9700983 A SE 9700983A SE 9700983 D0 SE9700983 D0 SE 9700983D0
Authority
SE
Sweden
Prior art keywords
cells
cellulose derivative
stimulation
pancreatic
culture
Prior art date
Application number
SE9700983A
Other languages
English (en)
Swedish (sv)
Inventor
Per Maansson
Tomas Lundin
Original Assignee
Ascendia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascendia Ab filed Critical Ascendia Ab
Priority to SE9700983A priority Critical patent/SE9700983D0/xx
Publication of SE9700983D0 publication Critical patent/SE9700983D0/xx
Priority to EP98909956A priority patent/EP0975739B1/de
Priority to AT98909956T priority patent/ATE393214T1/de
Priority to US09/381,650 priority patent/US6479283B1/en
Priority to CA002283676A priority patent/CA2283676C/en
Priority to AU64313/98A priority patent/AU6431398A/en
Priority to JP54043798A priority patent/JP4237265B2/ja
Priority to DE69839393T priority patent/DE69839393T2/de
Priority to PCT/SE1998/000475 priority patent/WO1998041617A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/50Soluble polymers, e.g. polyethyleneglycol [PEG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
SE9700983A 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler SE9700983D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler
EP98909956A EP0975739B1 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen
AT98909956T ATE393214T1 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen
US09/381,650 US6479283B1 (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic cells
CA002283676A CA2283676C (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells
AU64313/98A AU6431398A (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells
JP54043798A JP4237265B2 (ja) 1997-03-18 1998-03-16 膵臓およびその他の細胞の刺激、培養および保存
DE69839393T DE69839393T2 (de) 1997-03-18 1998-03-16 Stimulierung, züchtung und erhalt pankreatischer und anderer zellen
PCT/SE1998/000475 WO1998041617A1 (en) 1997-03-18 1998-03-16 Stimulation, culture and preservation of pancreatic and other cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler

Publications (1)

Publication Number Publication Date
SE9700983D0 true SE9700983D0 (sv) 1997-03-18

Family

ID=20406207

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700983A SE9700983D0 (sv) 1997-03-18 1997-03-18 Stimulering, odling och preservation av pankreas- och andra celler

Country Status (9)

Country Link
US (1) US6479283B1 (de)
EP (1) EP0975739B1 (de)
JP (1) JP4237265B2 (de)
AT (1) ATE393214T1 (de)
AU (1) AU6431398A (de)
CA (1) CA2283676C (de)
DE (1) DE69839393T2 (de)
SE (1) SE9700983D0 (de)
WO (1) WO1998041617A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8033401A (en) * 2000-06-28 2002-01-08 Ascendia Ab Dna/rna-embedding medium and method of use
US20040186180A1 (en) 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CA2666670A1 (en) * 2006-10-20 2008-05-02 Dow Global Technologies Inc. Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
DK2162531T3 (en) * 2007-05-04 2019-04-23 Ascendia Ab METHOD AND METHOD FOR CULTIVATING OSTEOBLASTIC CELLS
WO2009111022A1 (en) * 2008-03-07 2009-09-11 Corning Incorporated Hydrophobically modified cellulose ether derivatives for cell culture and release
CN102573860A (zh) 2009-10-02 2012-07-11 巴克斯特国际公司 用于治疗肾脏损伤的造血干细胞
AU2012272586B2 (en) * 2011-06-23 2016-07-07 The Children's Hospital Of Philadelphia Self-renewing endodermal progenitor lines generated from human pluripotent stem cells and methods of use thereof
JP2015508101A (ja) 2012-02-21 2015-03-16 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated Cd34+細胞を含む薬学的組成物
EP3167911A1 (de) * 2015-11-10 2017-05-17 Oniris In si-hpmc-eingekapselte insulinerzeugende zellen zur behandlung von typ-1-diabetes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038139A (en) * 1976-07-16 1977-07-26 G. D. Searle & Co., Limited Cell culture medium
US4104124A (en) * 1976-08-30 1978-08-01 Louisiana State University Foundation Process for the production of single cell protein and amino acids
DE2726313C3 (de) * 1977-06-10 1980-02-07 Battelle-Institut E.V., 6000 Frankfurt Verfahren zur in-vitro-Biosynthese von Hormonen, insbesondere von Insulin
US4330622A (en) * 1979-09-12 1982-05-18 Becton Dickinson & Co. Elimination of non-microbial turbidity in culture media
JPS56167624A (en) * 1980-05-29 1981-12-23 Toray Ind Inc Method of interferon production
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
DD282471A5 (de) * 1989-04-21 1990-09-12 Staatliches Inst Fuer Immunpra Verfahren zur kultivation von mikroorganismen
JPH03175973A (ja) * 1989-09-26 1991-07-31 Kirin Brewery Co Ltd 動物細胞培養用担体およびその製造法
DE4115722A1 (de) * 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen
IL102929A (en) * 1992-08-24 1996-11-14 Interpharm Lab Ltd Serum-free medium for mammalian cells
US5834308A (en) * 1994-04-28 1998-11-10 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of Langerhans
US5587309A (en) * 1994-04-29 1996-12-24 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating proliferation and differentiation of human fetal pancreatic cells ex vivo

Also Published As

Publication number Publication date
EP0975739B1 (de) 2008-04-23
WO1998041617A1 (en) 1998-09-24
DE69839393T2 (de) 2009-06-04
ATE393214T1 (de) 2008-05-15
JP4237265B2 (ja) 2009-03-11
JP2001521377A (ja) 2001-11-06
CA2283676C (en) 2004-11-02
CA2283676A1 (en) 1998-09-24
AU6431398A (en) 1998-10-12
DE69839393D1 (de) 2008-06-05
US6479283B1 (en) 2002-11-12
EP0975739A1 (de) 2000-02-02

Similar Documents

Publication Publication Date Title
Axelrod et al. Stimulation of C14-melatonin synthesis from C14-tryptophan by noradrenaline in rat pineal in organ culture
Lupton et al. Long-term effects of fermentable fibers on rat colonic pH and epithelial cell cycle
DE60029566T2 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
DE69801517D1 (de) Verfahren zur verhinderung der verkalkung von aldehyd-fixierten bioprothesenmaterialien
DE69232008D1 (de) Verwendung von insulinähnlichen Wachstumsfaktoren und Analogen zur BEHANDLUNG VON ERKRANKUNGEN DER SEHNERVEN
DK0871414T3 (da) Fremgangsmåder til fremstilling af væv til implantering
SE9700983D0 (sv) Stimulering, odling och preservation av pankreas- och andra celler
PL322015A1 (en) Derivatives of hydroxylamine useful as compounds enhancing production of accompanying molecular protein and ethod of obtaining them
AU562903B2 (en) Apparatus for sterilizing objects with an aqueous hypochlorite solution
DE69514924D1 (de) Zuführung exogener chemischer substanzen an pflanzengewebe
ATE93138T1 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
MX7708E (es) Procedimiento mejorado para estimular el crecimiento de plantas
ATE5854T1 (de) Zusammensetzungen zur verwendung bei der verminderung des appetites auf kohlenhydratkalorien.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
Sato et al. Phosphorylase: a new isozyme in rat hepatic tumors and fetal liver
GR1000719B (el) Μεθοδος παρασκευης της (s)-α-εθυλ-2-οξο-1-πυρρολιδινοακεταμιδης.
ATE254884T1 (de) Biologisch abbaubare vorrichtung
BR8202494A (pt) Processo para preparar tecido natural fixo bem como tecido natural fixo valvula cardiaca fixa de suino e tecido fixo de pericardio de bovino adequados para implante
CA2225898A1 (en) Enhancing keratinocyte migration and proliferation
DK0739354T3 (da) Præparater og fremgangsmåder, hvor der anvendes ikke-bundet MPL-receptor til stimulering af blodpladeproduktion
ATE23112T1 (de) Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks.
ES2180345T3 (es) Nuevo procedimiento para la crio-conservacion de plantas.
FR2600671B1 (fr) Procede de conservation cryogenique de substances et matieres organiques, notamment de cellules
GR1001093B (el) Απορροφητικό υλικό, μέ?οδος επίτευξης απορροφητικού υλικού, απορροφητικό υπό?εμα, μέ?οδος επίτευξης απορροφητικού υπο?έματος, και απορροφητικό αντικείμενο μιας χρήσεως.
Houlihan et al. Nerve growth-promoting properties of 1, 1, 3-tricyano-2-amino-1-propene